International Flavors & Fragrances vs Axon Enterprise
Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
About
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
Scottsdale public safety technology (NASDAQ: AXON); Taser + body cameras + AI evidence management, Carbyne $625M acquisition creates Axon 911 emergency response platform, 18,000+ law enforcement customers competing with Motorola Solutions.
About
Axon Enterprise, Inc. is a Scottsdale, Arizona-based public safety technology company — publicly traded on NASDAQ (NASDAQ: AXON) as an S&P 500 Industrials component — developing and selling conducted energy weapons (Taser), body-worn cameras, cloud-based digital evidence management, real-time operations software, and AI-driven public safety intelligence solutions to law enforcement agencies, military organizations, and corrections facilities worldwide through approximately 5,000 employees. Axon's Taser electric weapons (used by 18,000+ law enforcement agencies in 107 countries) define the conducted energy weapon category — but Axon has expanded beyond hardware into a comprehensive cloud-based public safety software platform: Axon Evidence (body camera video storage, evidence management, and prosecutorial disclosure), Axon Records (digital police reports), Axon Dispatch (AI-assisted dispatch), and Axon Draft One (AI-generated use-of-force reports from body camera audio). In a landmark 2025 expansion, Axon announced a $625 million cash acquisition of Carbyne — an emergency communications platform serving 250+ million people worldwide through next-generation 911 call routing, real-time location data, and AI dispatch situational intelligence — creating Axon 911, an integrated emergency response platform combining cloud-native 911 call management with AI-powered context delivery for dispatchers and first responders. The Carbyne acquisition is expected to close Q1 2026. CEO Rick Smith — Axon's founder, who invented the first Taser in the early 1990s after losing two childhood friends to gun violence — leads the company's mission-driven expansion into AI-powered public safety technology.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.